Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Oncotarget|November 1, 2014
BRAF vs RAS oncogenes: are mutations of the same pathway equal? Differential signalling and therapeutic implicationsEftychia Oikonomou, Evangelos Koustas, Maria Goulielmaki, et al.
Critical Reviews in Oncogenesis|April 2, 2018
Homeobox Gene Involvement in Normal Hematopoiesis and in the Pathogenesis of Childhood LeukemiasMaria Adamaki, Maria Goulielmaki, Ioannis Christodoulou, et al.
Critical Reviews in Oncogenesis|April 2, 2018
The Ideological Frame of the Genetic Basis of Cancer: The Important Role of miRNAsVassilis Zoumpourlis, Eleni Skourti, Maria Goulielmaki, et al.
Translational Oncology|October 20, 2022
The thin red line between the immune system and cancer evolutionConstantin N Baxevanis, Maria Goulielmaki, Maria Adamaki, et al.
Cancers|December 23, 2022
Combination Immunotherapy in Prostate CancerConstantin N Baxevanis, Maria Goulielmaki, Angelos D Gritzapis, et al.
Oncology Letters|March 29, 2021
Non-coding RNAs (miRNAs and lncRNAs) and their roles in lymphogenesis in all types of lymphomas and lymphoid malignanciesGeorgios Drillis, Maria Goulielmaki, Demetrios A Spandidos, et al.
Molecular Medicine Reports|September 18, 2020
[Comment] The COVID‑19 pandemic as a scientific and social challenge in the 21st centuryVassilios Zoumpourlis, Maria Goulielmaki, Emmanouil Rizos, et al.
Colloids and Surfaces. B, Biointerfaces|April 3, 2017
Drug nanocarriers for cancer chemotherapy based on microemulsions: The case of Vemurafenib analog PLX4720Ioanna Theochari, Maria Goulielmaki, Dganit Danino, et al.
Stem Cell Research & Therapy|December 12, 2018
Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic reviewIoannis Christodoulou, Maria Goulielmaki, Marina Devetzi, et al.
Pageof 4